According to a new report, published by KBV research, The Global PET-CT Scanner Device Market size is expected to reach $2.6 billion by 2027, rising at a market growth of 5.5% CAGR during the forecast period.
The Medium Slice Cardiology (64 Slices) segment generated maximum revenue in the Global PET-CT Scanner Device Market by Slice Count in 2020, thereby, achieving a market value of $1.1 billion by 2027. This is due to increased demand for medium slice scanners, the surge in applications of medium slice scanners, advancements in PET-CT scan devices, and an increase in the rate of imaging with medium slice scanners.
The 62Cu ATSM segment is showcasing a CAGR of 5.2% during (2021 - 2027). This is because Copper-64 possesses decay properties that enable positron emission tomography (PET) imaging and cancer-targeted treatment. Because of the greater half-life, 64Cu can be manufactured in regional or national cyclotron facilities and provided to local nuclear medicine departments with just a one-half-life loss.
The Diagnostic Centers segment has growth rate of 5.8% during (2021 - 2027). This is because of the growing number of diagnostic centers around the world. Moreover, many people prefer such centers over hospitals due to the long waiting time for tests in hospitals. PET scans are used to diagnose malignancies (breast cancer, lymphoma), Alzheimer's disease, and other neurological illnesses.
The Stationary Scanners segment is leading the Global PET-CT Scanner Device Market by Type in 2020, thereby, achieving a market value of $1.9 billion by 2027. This is due to the rise in demand for stationary scanners, a surge in patient awareness toward stationary scanners, advancements in PET-CT scan devices, rise in the number of cases of cancer, cardiology diseases, and the launch of effective products.
The Oncology segment has acquired high revenue in the Global PET-CT Scanner Device Market by Application in 2020, thereby, achieving a market value of $1.1 billion by 2027. This is due to an increase in the prevalence of cancer disease, a surge in patient awareness toward early diagnosis and treatment of cancer, changes in population lifestyle, and an increase in tobacco consumption.
The North America is the fastest growing region in the Global PET-CT Scanner Device Market by Region in 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $967.3 million by 2027. The Europe market is estimated to witness a CAGR of 5.1% during (2021 - 2027). Additionally, The Asia Pacific market would exhibit a CAGR of 6.1% during (2021 - 2027).
Full Report: https://www.kbvresearch.com/pet-ct-scanner-device-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Bruker Corporation, Toshiba Corporation, Siemens Healthineers AG (Siemens AG), General Electric (GE) Co. (GE Healthcare), Koninklijke Philips N.V., Shimadzu Corporation, Positron Corporation, PerkinElmer, Inc., Mediso Ltd., and Hitachi, Ltd. (Hitachi Healthcare).
By Slice Count
By Isotope/Detector Type
By Service Provider
By Type
By Application
By Geography
Companies Profiled
Unique Offerings 
